RxDoctor Payments Data

Isaac Yoshii, MD

Anesthesiology · Stanford, CANPI 1154636090

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $500 of the $660 with a category attached, or 75.8%. Bard Access Systems, Inc. accounts for 75.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $558 and has fallen 92.5% since, to $42 in 2025.

$660in general payments, 2019–2025

Across 9 payments — averaging $73.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Access Systems, Inc.$500
  • Avanos Medical$35
  • Edwards Lifesciences$30
  • Merck$25
  • Celltrion USA Inc.$23
  • Takeda Pharmaceuticals U.S.A., Inc.$19
  • plus $28 from 2 others

What the payments were for

  • Speaking & faculty fees$50076%
  • Food & beverage$16024%

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$660 in reported general payments places this provider in the 85th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California →

Medicare billing

Part B allowed, 2024
$60,411
Medicare patients
230
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →